What You Should Know:
Healthcare investment firm Patient Square Capital (“Patient Square”) forms Elevage Medical Technologies (“Elevage”), a new portfolio company to support the growth of promising medical device companies by providing capital and deep strategic expertise.
Elevage will deliver financial and strategic growth support to a broad set of medical device technology companies that are at the forefront of transforming health care through cutting-edge devices that enhance health outcomes and quality of life for patients. Patient Square has made a capital commitment of $300M to Elevage Medical Technologies.
Elevage will be led by newly appointed CEO Evan Melrose, M.D., who brings more than 25 years of experience in health care across clinical, investment, and operational roles.
